SCHEMBL5226562

SCHEMBL5226562

CN(C)[S+]([O-])N(CC(=O)O)Cc1ccc(OCCc2coc(-c3ccccc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.51
PPARA Q07869 17/20 0.50
PPARG P37231 15/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5268317 0.91 PPARA (0.57) PPARAPPARG
SCHEMBL5225150 0.81 FFAR1 (0.52) FFAR1PPARAPPARG
SCHEMBL10184451 0.79 PPARA (0.72) FFAR1PPARAPPARG
SCHEMBL10184446 0.77 PPARA (0.71) FFAR1PPARAPPARG
SCHEMBL13542481 0.76 PPARG (0.62) FFAR1PPARAPPARG
SCHEMBL5229490 0.76 PPARA (0.50) FFAR1PPARAPPARG
SCHEMBL5223683 0.76 FFAR1 (0.46) FFAR1PPARAPPARG
SCHEMBL5225160 0.75 FFAR1 (0.48) FFAR1PPARAPPARG
SCHEMBL4748088 0.75 FFAR1 (0.59) FFAR1PPARAPPARG
SCHEMBL8839591 0.75 FFAR1 (0.57) FFAR1PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP disclosed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO disclosed